Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
133,817,301
-
Share change
-
+18,866,712
-
Total reported value
-
$303,707,293
-
Put/Call ratio
-
81%
-
Price per share
-
$2.27
-
Number of holders
-
163
-
Value change
-
+$43,340,422
-
Number of buys
-
65
-
Number of sells
-
87
Institutional Holders of PDL BIOPHARMA INC COM - COM (Y104L) as of Q1 2017
As of 31 Mar 2017,
PDL BIOPHARMA INC COM - COM (Y104L) was held by
163 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
133,817,301 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, CITADEL ADVISORS LLC, ACADIAN ASSET MANAGEMENT LLC, MACKENZIE FINANCIAL CORP, AQR CAPITAL MANAGEMENT LLC, STATE STREET CORP, and ROYAL BANK OF CANADA.
This page lists
163
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.